Clinical Trial Update: Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of postoperative mFOLFIRINOX as adjuvant chemotherapy for resectable pancreatic cancer in Chinese patients is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Yuhong Li | Conditions: Pancreatic Cancer Resectable | Phase 2 | Status: COMPLETED